Tumor Molecular Profiling
Learn More About Tumor Molecular Profiling: Chat with Us | Email Us
Video: Molecular TestingDr. Ritwick Panicker, a medical oncologist and hematologist at Cancer Treatment Centers of America, explains molecular testing and how it enables doctors to personalize cancer treatment.
Dr. Ritwick Panicker, a medical oncologist and hematologist at Cancer Treatment Centers of America, explains molecular testing and how it enables doctors to personalize cancer treatment.
Advanced Diagnostic: Tumor Molecular Profiling
Our goal at Cancer Treatment Centers of America (CTCA) is to develop a cancer treatment plan personalized to your needs. We perform tumor molecular profiling to identify chemotherapy drugs and other targeted therapies that have clinical benefits and may be more likely to work for you.
By choosing more effective drugs, we can avoid unnecessary toxicity to you and target cancer cells as aggressively as possible from the start.
Our oncologists use tumor molecular profiling to:
- Identify the unique the molecular “blueprint” of each patient’s tumor.
- Choose cancer treatments that are more likely to be effective and rule out those that are unlikely to be effective, on an individual patient basis – minimizing trial and error.
- Discover potentially beneficial treatment options that may not have been considered in an initial treatment plan.
What Is Molecular Profiling?
Every cancer cell has its own pattern of active genes and proteins. Molecular profiling tests for a variety of biomarkers in the DNA of a tissue sample to help us better diagnose, stage and treat cancer on an individualized basis.
We use CarisTarget Now™ Molecular Profiling, a comprehensive tumor analysis test that matches therapies to your specific biomarker information to develop an evidence- based treatment plan.
If you have a solid tumor, we’ll try to get a sample of tissue during a biopsy or surgery . Then, we’ll test for the presence of a variety of enzymes, proteins and genes to identify which therapies are likely to be most effective.
By comparing the tumor's information with data from thousands of clinical cancer research studies, the test identifies which treatments are likely to be most effective and which treatments are likely to be ineffective. This provides us with more and better information to develop a personalized treatment plan for you.
Who Is Right for Target Now?
- Patients with solid tumors.
- Patients with highly aggressive cancers that may not respond or have not responded to standard of care therapies.
- Patients with rare tumor types.
- Abdomen Biopsy
- Abscess Drainage and Fluid Collection Management
- All Digital: Portable Fluoroscopy and X-Rays
- Angiography with 3D CT
- Arterial Infusion Catheter Placement
- Autofluorescence Bronchoscopy / Fluorescence Bronchoscopy
- Biliary Drainage (internal / external stent placement)
- Blood Tests (see Complete Blood Count Test)
- Bone and Soft Tissue Biopsy
- Bone Marrow Biopsy
- Bone Scan (also see Sodium Fluoride PET/CT Bone Scan)
- Breast Biopsy (see MRI-Guided Breast Biopsy)
- Breast Ductography
- Breast Needle Localization
- CA-125 Test
- Cardiopulmonary Services
- CellSearch™ Circulating Tumor Cell (CTC) Test
- Chemoresistance (see Tumor Molecular Profiling)
- Chemotherapy Resistance Testing (see Tumor Molecular Profiling)
- Chest Biopsy
- Chest X-Ray
- Cholangiopancreatography (see ERCP)
- Cholangioscopy (see ERCP)
- Complete Blood Count (CBC) Test
- Computed Tomography (CT) Scan
- Computer-Aided Detection (CAD) Mammography
- CT Angiography
- CT Bone Density
- CT Fluoroscopy
- CT Scan
- CT-Guided Biopsy
- Dexa Scan (Bone Density Scan)
- Diagnostic and Interventional Multi-Detector CT
- Discovery™ PET/CT 600 Scanner
- 2D Echocardiogram
- Electrocardiogram (EKG)
- Endobronchial Ultrasound (EBUS)
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Endoscopic Ultrasound (EUS)
- Extreme Drug Resistance (see Tumor Molecular Profiling)
- Fine Needle Aspiration (FNA)
- Flexible Sigmoidoscopy
- Flow Cytometry
- Fluorescence Bronchoscopy
- Full Field Digital Mammography
- GE 16-slice CT Scanner / GE Volumetric CT Scanner
- GE Discovery™ PET/CT 600 Scanner
- Genetics Counseling
- Genetics Testing
- Inferior Vena Cava (IVC) Filter Placement
- Interventional Angiography
- Interventional Radiology
- Intraoperative Ultrasound
- Large Bore CT/RT with Simulation
- LightSpeed® RT
- Liver Function Tests
- Lumbar Puncture (Spinal Tap)
- Lung Biopsy
- Lung Capacity Studies
- Lung Nodule Analysis
- Lymph Node Biopsy
- Magnetic Resonance Imaging (MRI)
- Mammography Suite
- Microwave Ablation
- Miraluma Breast Imaging
- MR Computer-Aided Detection (CAD)
- MR Computer-Aided Detection (CAD) for Mammography
- MRI-Guided Breast Biopsy
- Multi-Slice CT Scan
- Multidetector CT Scanner
- Multiple Lymph Node Biopsy
- Multiple-Gated Acquisition (MUGA) Scan
- Navigational Bronchoscopy
- Nephrostomy Drainage (external and/or internal)
- Nuclear Medicine Imaging
- Oncotype DX® Test
- PCA3 (Prostate Cancer Antigen 3 Gene) Gene Testing
- Pelvis Biopsy
- PET Scan
- PET/CT and Molecular Imaging
- PET/CT Scan (also see Discovery™ PET/CT 600 Scanner)
- Point of Care Testing (POCT): Blood draws and lab testing performed at bedside/exam room
- Positron Emission Tomography (PET) Scan
- Prostascint® Scan
- Prostate-Specific Antigen (PSA) Test
- ProstaVysion (Genetic Test)
- Pulmonary Function Testing (PFT)
- Radiofrequency Ablation (RFA)
- Radiology Information System: All digital, paperless environment and voice recognition diction
- Respiratory Gating
- Sentinel Lymph Node Biopsy
- Sentinel Lymph Node Mapping and Imaging
- Siemens / GE Multi-Modality Workstation
- Siemens ACUSON S2000TM Ultrasound System
- Sim Capable
- Sodium Fluoride PET/CT Bone Scan
- Soft Tissue Biopsy
- SPECT/CT Camera for Nuclear Studies
- Spiral Computed Tomography (CT)
- SpyGlass™ (Cholangioscopy)
- Surgical Radiography
- Transrectal Ultrasound
- Tumor Markers
- Tumor Molecular Profiling
- Tumor Tissue Repository
- Urine Tests
- Video Capsule Endoscopy